ArticlePloS one2023

Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization.

Aya Kamimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.